GSK Bexsero Wins CHMP Support for Single-Dose MenB Boosters
London, United Kingdom, November 13, 2026 GSK plc has announced that its Bexsero (4CMenB) meningococcal group B vaccine has...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
London, United Kingdom, November 13, 2026 GSK plc has announced that its Bexsero (4CMenB) meningococcal group B vaccine has...
Beijing, China, and Bridgewater, Massachusetts, United States, November 4, 2026 Gan & Lee Pharmaceuticals has announced positive topline results...
